Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1551194

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to monitor the national availability of HRT.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109778
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, factors including an increase in demand has led to supply issues with a limited number of products. We regularly engage with suppliers, the National Health Service and the Medicines and Healthcare products Regulatory Agency to maintain overall supply, including expediting resupply dates of disrupted HRT products.</p><p>We have issued Serious Shortage Protocols (SSPs) on HRT products to ensure an even distribution and allow alternative products to be dispensed as necessary. Since April 2022, 17 SSPs for HRT products have been issued and seven remain in place as the supply of several products affected by short term supply issues has been resolved. We regularly communicate with the NHS on shortages and discontinuations, including HRT products currently affected by supply issues and via the Specialist Pharmacy Service Medicine Supply tool.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/12/2022 17:06:01 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1551198

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Estradiol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the availability of Estradiol Sandrena gel sachets in each region.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109780
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, a range of factors including an increase in demand has led to issues with a limited number of products.</p><p>There are currently Serious Shortage Protocols (SSP) in place for Sandrena gel, Lenzetto spray and Estraderm MX 75 microgram patches. We are aware of ongoing supply issues with these products and have extended the SSP</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 109781 109782 question first answered 20/12/2022 16:03:32 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1551199

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Estradiol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the availability of Estraderm patches in each region.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109781
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, a range of factors including an increase in demand has led to issues with a limited number of products.</p><p>There are currently Serious Shortage Protocols (SSP) in place for Sandrena gel, Lenzetto spray and Estraderm MX 75 microgram patches. We are aware of ongoing supply issues with these products and have extended the SSP</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 109780 109782 question first answered 20/12/2022 16:03:32 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1551200

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Estradiol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the availability of Estradiol Lenzetto spray in each region.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109782
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, a range of factors including an increase in demand has led to issues with a limited number of products.</p><p>There are currently Serious Shortage Protocols (SSP) in place for Sandrena gel, Lenzetto spray and Estraderm MX 75 microgram patches. We are aware of ongoing supply issues with these products and have extended the SSP</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 109780 109781 question first answered 20/12/2022 16:03:32 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1551201

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fluoxetine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the availability of Fluoxetine in each region.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109783
answer	answer is ministerial correction date of answer 19/12/2022 answer text <p>There is currently a Serious Shortage Protocol in place for fluoxetine 10 milligram tablets, which allows pharmacists to supply a specified alternative fluoxetine product. All other fluoxetine products remain available.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/12/2022 17:44:07 answering member 4423 label Biography information for Will Quince
tabling member	4657 label Biography information for Anneliese Dodds

1551202

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to collect data on the availability of hormonal replacement therapy products (a) with and (b) without serious shortage protocols.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109784
answer	answer is ministerial correction date of answer 21/12/2022 answer text <p>We are working with suppliers of hormonal replacement therapy (HRT) to collect data on the availability of their products.</p><p> </p><p>We are also working to improve access to demand data, including prescriptions and dispensing from the NHS Business Service Authority. This is being used to monitor whether there are shortfalls between HRT packs prescribed and HRT packs supplied by manufacturers.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 21/12/2022 17:14:06 answering member 4492 label Biography information for Maria Caulfield previous answer version 43988 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1551204

registered interest
date	13/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy: Shortages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 December 2022 to Question 104415 on Hormone Replacement Therapy: Shortages, for what reason some serious shortage protocols have been extended into 2023.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	109785
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>In 2022, 17 Serious Shortage Protocols (SSPs) were issued to mitigate supply issues affecting hormone replacement therapy (HRT) medicines. SSPs can be extended or withdrawn to take account of changing supply situations and 10 of these SSPs have subsequently been withdrawn due to improvements in supply. As the industry ensures there is a long-term, sustainable supply of HRT products to meet demand, we are taking precautionary action by extending some SSPs to improve availability of products still affected by supply issues.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/12/2022 16:10:18 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1549361

registered interest
date	07/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Infant Foods: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the average cost of safely feeding a baby requiring infant formula for the first six months of its life.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	105480
answer	answer is ministerial correction date of answer 16/12/2022 answer text <p>There are no current plans to make such an estimate.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 16/12/2022 12:38:37 answering member 4679 label Biography information for Neil O'Brien previous answer version 42232 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4657 label Biography information for Anneliese Dodds

1549362

registered interest
date	07/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Infant Foods: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of Healthy Start vouchers for funding the cost of infant formula.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	105481
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>The Healthy Start scheme is kept under continuous review.</p><p>In April 2021, the value of the Healthy Start benefit was raised from £3.10 to £4.25 per week, providing additional support to pregnant women and families on lower incomes to make healthy food choices. Children aged under one year old receive £8.50 per week, an increase from £6.20.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 20/12/2022 17:21:55 answering member 4679 label Biography information for Neil O'Brien previous answer version 42233 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4657 label Biography information for Anneliese Dodds

1548934

registered interest
date	06/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy: Shortages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of reports of shortages of hormonal replacement therapies.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	104412
answer	answer is ministerial correction date of answer 12/12/2022 answer text <p>There are over 70 hormone replacement therapy (HRT) products available in the United Kingdom and while most remain in good supply, a range of factors including an increase in demand has led to issues with a limited number of products. We have been working with suppliers, stakeholders and the National Health Service and the Medicines and Healthcare products Regulatory Agency to maintain overall supply, including expediting resupply dates of the disrupted HRT products.</p><p> </p><p>Since Serious Shortage Protocols (SSPs) on specific HRT products were introduced to ensure even distribution and allow alternative products to be dispensed, supplies have now improved and recently, several SSPs have been removed. Suppliers have secured additional stock of products experiencing shortages and deliveries have been expedited. We share regular communications on shortages, discontinuations and supply information with the NHS.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 104413 104414 104415 question first answered 12/12/2022 12:08:19 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds